Tianshui Zhongxing Bio-technology Co.,Ltd.

SZSE:002772 株式レポート

時価総額:CN¥2.7b

Tianshui Zhongxing Bio-technologyLtd 将来の成長

Future 基準チェック /06

We currently don't have sufficient analyst coverage to forecast growth and revenue for Tianshui Zhongxing Bio-technologyLtd.

主要情報

n/a

収益成長率

n/a

EPS成長率

Food 収益成長22.1%
収益成長率n/a
将来の株主資本利益率n/a
アナリストカバレッジ

None

最終更新日n/a

今後の成長に関する最新情報

更新なし

Recent updates

Tianshui Zhongxing Bio-technologyLtd's (SZSE:002772) Anemic Earnings Might Be Worse Than You Think

Nov 02
Tianshui Zhongxing Bio-technologyLtd's (SZSE:002772) Anemic Earnings Might Be Worse Than You Think

These Return Metrics Don't Make Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Look Too Strong

Oct 01
These Return Metrics Don't Make Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Look Too Strong

Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Has Affirmed Its Dividend Of CN¥0.30

May 12
Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Has Affirmed Its Dividend Of CN¥0.30

Tianshui Zhongxing Bio-technology Co.,Ltd. (SZSE:002772) Held Back By Insufficient Growth Even After Shares Climb 37%

Mar 15
Tianshui Zhongxing Bio-technology Co.,Ltd. (SZSE:002772) Held Back By Insufficient Growth Even After Shares Climb 37%

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Tianshui Zhongxing Bio-technologyLtd は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

SZSE:002772 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
9/30/20241,89573217417N/A
6/30/20241,827-8188358N/A
3/31/20241,795-4181341N/A
12/31/20231,931160395502N/A
9/30/20231,978216400537N/A
6/30/20232,130376528686N/A
3/31/20232,105342411627N/A
1/1/20231,970158248494N/A
9/30/20221,94222235-221N/A
6/30/20221,71122-436-389N/A
3/31/20221,64926-663-382N/A
12/31/20211,55655-700-414N/A
9/30/20211,50819-506338N/A
6/30/20211,554145-261320N/A
3/31/20211,51215810345N/A
12/31/20201,48318910389N/A
9/30/20201,422150-81339N/A
6/30/20201,28075-116360N/A
3/31/20201,21576-232368N/A
12/31/20191,15668-304359N/A
9/30/20191,01045-331285N/A
6/30/20191,021127-384346N/A
3/31/201996791-420274N/A
12/31/2018926112-420232N/A
9/30/2018910143-458235N/A
6/30/2018835113N/A196N/A
3/31/2018839180N/A251N/A
12/31/2017740142N/A207N/A
9/30/2017683144N/A233N/A
6/30/2017639147N/A215N/A
3/31/2017571122N/A185N/A
12/31/2016585159N/A233N/A
9/30/2016575167N/A227N/A
6/30/2016539151N/A226N/A
3/31/2016533154N/A245N/A
12/31/2015480114N/A209N/A
9/30/2015444102N/A190N/A
6/30/201542595N/A170N/A
3/31/201539986N/A169N/A
12/31/201438391N/A170N/A
12/31/201326455N/A93N/A

アナリストによる今後の成長予測

収入対貯蓄率: Insufficient data to determine if 002772's forecast earnings growth is above the savings rate (2.9%).

収益対市場: Insufficient data to determine if 002772's earnings are forecast to grow faster than the CN market

高成長収益: Insufficient data to determine if 002772's earnings are expected to grow significantly over the next 3 years.

収益対市場: Insufficient data to determine if 002772's revenue is forecast to grow faster than the CN market.

高い収益成長: Insufficient data to determine if 002772's revenue is forecast to grow faster than 20% per year.


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: Insufficient data to determine if 002772's Return on Equity is forecast to be high in 3 years time


成長企業の発掘